MedTrace Logo

Observation for Patients With Asymptomatic CNS Metastatic Disease

NCT02866981 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 33

Last updated 2018-05-09

No results posted yet for this study

Summary

The purpose of this registry is to determine if select patients with CNS metastatic disease can be safely observed rather than treated. The investigators hypothesize that there is a subset of patients with small asymptomatic CNS mets that do not require treatment, these patients can simply be observed and will not have CNS progression.

Conditions

Interventions

OTHER

Observation

Sponsors & Collaborators

  • The Cooper Health System

    lead OTHER

Principal Investigators

  • Harry Mazurek, MD · Cooper University Health System

  • Gregory Kubicek, MD · Cooper University Health System

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-02-28
Primary Completion
2017-12-01
Completion
2017-12-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02866981 on ClinicalTrials.gov